It has also been found that overexpression of Cav-1 can be helpful for the treatment of CML by realgar NPs by activating autophagy, decreasing the proliferation of CML cells and increasing the sensitivity of K562 cells to realgar NPs (101). Here, CAV1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.